Vor Biopharma Inc.
VOR- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001817229
In the last 90 days, Vor Biopharma Inc. insiders filed 0 open-market purchases and 1 sale; 102 institutions reported holding it in 13F filings for Q2 2026, worth $893.0M in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Vor Biopharma Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 55
- +18 vs. Q3 2025
- Shares held
- 25.5M
- +21.8M (+578.7%) vs. Q3 2025
- Total value
- $332.0M
- +$148.6M (+81.1%) vs. Q3 2025
- New holders
- 28
- 19 more added
- Sold out
- 10
- 2 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VOR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 102 | $893.0M |
| Q1 2026 | 80 | $716.9M |
| Q4 2025 | 55 | $332.0M |
| Q3 2025 | 37 | $183.4M |
| Q2 2025 | 35 | $91.9M |
| Q1 2025 | 46 | $43.2M |
| Q4 2024 | 52 | $67.6M |
| Q3 2024 | 54 | $33.5M |
| Q2 2024 | 71 | $54.5M |
| Q1 2024 | 69 | $139.7M |
| Q4 2023 | 60 | $134.1M |
| Q3 2023 | 59 | $127.7M |
| Q2 2023 | 71 | $187.8M |
| Q1 2023 | 60 | $325.7M |
| Q4 2022 | 58 | $400.3M |
| Q3 2022 | 48 | $125.5M |
| Q2 2022 | 49 | $154.8M |
| Q1 2022 | 58 | $187.9M |
| Q4 2021 | 61 | $362.0M |
| Q3 2021 | 55 | $481.2M |
| Q2 2021 | 51 | $571.2M |
| Q1 2021 | 49 | $1.31B |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Vor Biopharma Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 7 | $0 | 0.00% | +5+250.0% | Added |
| Wells Fargo & Company | 1 | $13 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 3 | $39 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 3 | $40 | 0.00% | 00.0% | Unchanged |
| MAI Capital Management | 40 | $524 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 291 | $3.81K | 0.00% | −5,784−95.2% | Reduced |
| GF Fund Management Co. Ltd. | 330 | $4.32K | 0.00% | +330 | New |
| Bank of America Corp | 396 | $5.18K | 0.00% | −4,358−91.7% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 819 | $10.7K | 0.00% | +819 | New |
| Barclays PLC | 1,399 | $18.3K | 0.00% | +1,399 | New |
| Tower Research Capital LLC (TRC) | 1,729 | $22.6K | 0.00% | +1,725+43,125.0% | Added |
| JPMorgan Chase & Co | 2,312 | $30.2K | 0.00% | +2,234+2,864.1% | Added |
| China Universal Asset Management Co., Ltd. | 2,746 | $35.9K | 0.00% | +2,746 | New |
| Hudson Bay Capital Management LP | 5,110 | $66.8K | 0.00% | +5,110 | New |
| Citigroup Inc | 6,340 | $82.9K | 0.00% | +6,340 | New |
| Chung Wu Investment Group, LLC | 8,300 | $108.6K | 0.09% | +8,300 | New |
| Susquehanna Portfolio Strategies, LLC | 10,207 | $133.5K | 0.00% | +10,207 | New |
| Shay Capital LLC | 10,745 | $140.5K | 0.02% | +10,745 | New |
| Persistent Asset Partners Ltd | 10,798 | $141.2K | 0.07% | +10,798 | New |
| Susquehanna International Group, LLP | 14,819 | $193.8K | 0.00% | +14,819 | New |
| Independent Financial Group, LLC | 17,000 | $222.4K | 0.00% | +17,000 | New |
| XTX Topco Ltd | 17,542 | $229.4K | 0.01% | +17,542 | New |
| Squarepoint Ops LLC | 18,459 | $241.4K | 0.00% | +13,730+290.3% | Added |
| Omers Administration Corp | 20,700 | $270.8K | 0.00% | +20,700 | New |
| Bollard Group LLC | 23,987 | $314.0K | 0.01% | +21,210+763.8% | Added |
| Sarissa Capital Management LP | 25,399 | $332.2K | 0.15% | 00.0% | Unchanged |
| Quadrature Capital Ltd | 26,791 | $350.4K | 0.00% | +26,791 | New |
| Engineers Gate Manager LP | 28,204 | $368.9K | 0.00% | +28,204 | New |
| Morgan Stanley | 28,463 | $372.3K | 0.00% | +24,007+538.8% | Added |
| Northern Trust Corp | 38,946 | $509.4K | 0.00% | +38,946 | New |
| Johnson & Johnson | 53,732 | $702.8K | 0.13% | 00.0% | Unchanged |
| State Street Corp | 91,053 | $1.19M | 0.00% | +81,999+905.7% | Added |
| Jane Street Group, LLC | 91,810 | $1.20M | 0.00% | +75,057+448.0% | Added |
| Logos Global Management LP | 100,000 | $1.31M | 0.09% | +100,000 | New |
| Goldman Sachs Group Inc | 145,640 | $1.90M | 0.00% | +129,854+822.6% | Added |
| Ameriprise Financial Inc | 163,061 | $2.13M | 0.00% | +163,061 | New |
| Tudor Investment Corp Et Al | 167,673 | $2.19M | 0.01% | +167,673 | New |
| Geode Capital Management, LLC | 185,808 | $2.43M | 0.00% | +158,416+578.3% | Added |
| Millennium Management LLC | 224,534 | $2.94M | 0.00% | +199,770+806.7% | Added |
| Findell Capital Management LLC | 231,000 | $3.02M | 1.00% | +231,000 | New |
| UBS Group AG | 292,118 | $3.82M | 0.00% | +216,209+284.8% | Added |
| Laurion Capital Management LP | 317,243 | $4.15M | 0.28% | +317,243 | New |
| Sphera Funds Management Ltd. | 410,417 | $5.37M | 1.12% | +410,417 | New |
| Citadel Advisors LLC | 433,894 | $5.68M | 0.00% | +428,208+7,530.9% | Added |
| BlackRock, Inc. | 465,636 | $6.09M | 0.00% | +431,106+1,248.5% | Added |
| Caligan Partners LP | 925,067 | $9.96M | 0.91% | +925,067 | New |
| Vanguard Group Inc | 770,250 | $10.1M | 0.00% | +665,060+632.2% | Added |
| NEXTBio Capital Management LP | 999,967 | $13.1M | 7.67% | +999,967 | New |
| Great Point Partners LLC | 1,370,107 | $17.9M | 5.81% | +1,370,107 | New |
| Paradigm Biocapital Advisors LP | 1,750,000 | $22.9M | 0.61% | +1,750,000 | New |
| VR Adviser, LLC | 1,943,766 | $25.4M | 1.26% | +1,443,800+288.8% | Added |
| FMR LLC | 2,526,170 | $33.0M | 0.00% | +2,289,662+968.1% | Added |
| Frazier Life Sciences Management, L.P. | 2,543,939 | $33.3M | 0.89% | +2,543,939 | New |
| FCPM III Services B.V. | 3,617,354 | $47.3M | 6.20% | +3,237,714+852.8% | Added |
| Ra Capital Management, L.P. | 5,404,998 | $70.7M | 0.72% | +3,422,697+172.7% | Added |
| Ariose Capital Management Ltd | 0 | $0 | 0.00% | −110,173−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −27,363−100.0% | Sold out |
| Polymer Capital Management (HK) LTD | 0 | $0 | 0.00% | −21,248−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −14,600−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −8,104−100.0% | Sold out |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −6,250−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −6,097−100.0% | Sold out |
| Trustees of Columbia University in the City of New York | 0 | $0 | 0.00% | −4,595−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −110−100.0% | Sold out |